Search results
7 of this week's most noteworthy health stories, in case you missed them
Fox News· 4 days agoFox News Digital publishes a range of health pieces every day of the week to keep you up-to-date on...
Cantargia ASCO Presentation Highlights Positive Clinical Data on Nadunolimab Counteracting...
Morningstar· 4 days agoLUND, SWEDEN / ACCESSWIRE / June 1, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today gave a presentation at the ASCO conference showing clinical data on nadunolimab counteracting the serious problem of chemotherapy